SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008625
Filing Date
2020-05-14
Accepted
2020-05-14 09:21:34
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 469861
2 ex31-1.htm EX-31.1 15937
3 ex31-2.htm EX-31.2 15748
4 ex32-1.htm EX-32.1 7346
  Complete submission text file 0001493152-20-008625.txt   2634095

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pulm-20200331.xml EX-101.INS 380549
6 XBRL SCHEMA FILE pulm-20200331.xsd EX-101.SCH 35076
7 XBRL CALCULATION FILE pulm-20200331_cal.xml EX-101.CAL 47326
8 XBRL DEFINITION FILE pulm-20200331_def.xml EX-101.DEF 117481
9 XBRL LABEL FILE pulm-20200331_lab.xml EX-101.LAB 253305
10 XBRL PRESENTATION FILE pulm-20200331_pre.xml EX-101.PRE 194864
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 20875564
SIC: 2834 Pharmaceutical Preparations